Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Good Girl LLC dba GoodGirlRX
WARNING LETTER
•Good Girl LLC dba GoodGirlRX•December 31, 2025

Good Girl LLC dba GoodGirlRX – FDA Warning Letter, Dec 31, 2025

Record Details

On February 20, 2026, the FDA issued a Warning Letter to Good Girl LLC dba GoodGirlRX, following a December 2025 review of its website. The letter addresses significant violations concerning the promotion and sale of compounded semaglutide and tirzepatide drug products. The primary issues identified include misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act (FDCA), and prohibited acts under section 301(a) of the FDCA. GoodGirlRX falsely presented itself as the compounder of these drugs on product labels depicted on its website. Furthermore, the company made unsubstantiated claims such as "FDA-approved meds," "FDA-approved options," and "Clinically proven GLP-1 results." Compounded drugs are not FDA-approved, and these claims misleadingly imply that the products have been evaluated for safety and effectiveness. The FDA requires GoodGirlRX to take immediate corrective action. The company must provide a written response within 15 working days, detailing steps taken to rectify the violations and prevent recurrence. Specific requirements include identifying the actual entities compounding the products, submitting representative product labeling, and either demonstrating the basis for other website claims or confirming their modification or removal to comply with FDCA regulations. Failure to address these issues promptly may lead to legal action.

Company
Good Girl LLC dba GoodGirlRX
Inspection date
December 31, 2025
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Matthew J. Lash (Acting Director)
  • Savannah Chrisley
View Company Profile

ID · 2713fdb1-a7de-4c4d-a8dc-c896305218d1

Violation Codes10
FD&C Act 502(a)FD&C Act 502(b)21 U.S.C. 352(a)21 U.S.C. 352(bb)FD&C Act 301(a)21.U.S.C. 331(a)FD&C Act 301(c)21 U.S.C. 331(c)FD&C Act 503AFD&C Act 503B

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Good Girl LLC dba GoodGirlRX
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.